Omar Samee

NPI: 1831174077
Total Payments
$33.01
2021 Payments
$33.01
Companies
1
Transactions
4
Medicare Patients
1,095
Medicare Billing
$67,191

Payment Breakdown by Category

Food & Beverage$33.01 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $33.01 4 100.0%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $33.01 4 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $33.01 4 Genentech USA, Inc. ($33.01)

All Payment Transactions

4 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/15/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $10.13 General
Category: Virology & Specialty Care
11/01/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $2.16 General
Category: Virology & Specialty Care
03/10/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $9.21 General
Category: Virology & Specialty Care
02/11/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $11.51 General
Category: Virology & Specialty Care

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 209 224 $52,734 $12,270
2022 8 301 345 $68,066 $18,089
2021 9 321 378 $73,637 $21,215
2020 5 264 278 $64,010 $15,618
Total Patients
1,095
Total Services
1,225
Medicare Billing
$67,191
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 55 55 $17,525 $3,936 22.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 52 53 $13,477 $2,651 19.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 19 19 $7,938 $2,074 26.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 25 25 $8,072 $1,893 23.5%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 32 32 $3,032 $1,108 36.5%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 15 29 $1,595 $470.38 29.5%
71046 X-ray of chest, 2 views Office 2023 11 11 $1,095 $136.93 12.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 88 104 $28,715 $6,529 22.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 59 59 $16,950 $4,145 24.5%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 56 57 $4,275 $2,397 56.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 24 27 $8,640 $2,287 26.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 15 15 $5,250 $1,856 35.3%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 21 42 $2,310 $683.86 29.6%
96372 Injection of drug or substance under skin or into muscle Office 2022 13 16 $1,440 $135.71 9.4%
81003 Automated urinalysis test Office 2022 25 25 $486.00 $55.51 11.4%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 76 76 $20,425 $6,577 32.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 74 84 $22,410 $5,822 26.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 42 43 $14,780 $3,596 24.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 30 30 $10,470 $2,523 24.1%
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc Office 2021 32 33 $2,475 $1,693 68.4%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 18 18 $1,350 $814.14 60.3%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 18 18 $1,087 $138.18 12.7%
81003 Automated urinalysis test Office 2021 20 21 $420.00 $47.25 11.3%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2021 11 55 $220.00 $3.88 1.8%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 111 111 $29,030 $7,910 27.2%

About Omar Samee

Omar Samee is a Physician Assistant healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831174077.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Omar Samee has received a total of $33.01 in payments from pharmaceutical and medical device companies, with $33.01 received in 2021. These payments were reported across 4 transactions from 1 company. The most common payment nature is "Food and Beverage" ($33.01).

As a Medicare-enrolled provider, Samee has provided services to 1,095 Medicare beneficiaries, totaling 1,225 services with total Medicare billing of $67,191. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Pasadena, TX
  • Active Since 12/09/2005
  • Last Updated 04/28/2008
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1831174077

Products in Payments

  • Xofluza (Drug) $33.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Pasadena